UCB, Inc.
Drug manufacturer · manufacturer
Unclaimed listing
45
Drug products
2
Therapeutic areas
About
UCB, Inc. is listed in the FDA National Drug Code Directory with 45 marketed products, of which 45 are prescription drugs. Dosage forms include INJECTION, TABLET, SOLUTION, POWDER, SPRAY. Portfolio includes DEA-scheduled controlled substances.
What UCB, Inc. makes
45 products- Bimzelxbimekizumab
- Bimzelxbimekizumab
- Bimzelxbimekizumab
- Bimzelxbimekizumab
- Briviactbrivaracetam
- Briviactbrivaracetam
- Briviactbrivaracetam
- Briviactbrivaracetam
- Briviactbrivaracetam
- Briviactbrivaracetam
- Briviactbrivaracetam
- Cimziacertolizumab pegol
- Cimziacertolizumab pegol
- Cimziacertolizumab pegol
- KYGEVVIdoxecitine and doxribtimine
- Finteplafenfluramine
- Vimpatlacosamide
- Vimpatlacosamide
- Vimpatlacosamide
- Vimpatlacosamide
- Vimpatlacosamide
- Vimpatlacosamide
- Keppralevetiracetam
- Keppralevetiracetam
Page 1 of 2Next ›
Get a price
This listing is unclaimed, so post your requirement and every verified pharmacy licensed in your state will bid.
Request a quoteContact
Email and website are not published in the public registries — they are added when the listing is claimed.
From the FDA NDC Directory, refreshed 2026-08-15.
Is this your business?
Claim the listing to publish your catalog, answer buyer enquiries and bid on sourcing requests.
Claim this listing